Breast implant retrospective registry
This article was originally published in The Gray Sheet
Executive Summary
Current and former breast implant manufacturers met with device center staffers Feb. 9 to discuss development of the registry. Firms including Dow Corning, Mentor, Baxter Healthcare, Bioplasty, McGhan parent Inamed, Bristol- Myers Squibb and Surgitek are formulating plans to create a voluntary registry that would operate using industry funds. Discussions of the registry were initiated by FDA in April in response to the silicone gel-filled breast implant controversy ("The Gray Sheet" April 20, 1992, p. 1).
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.